Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 30 and 75 years old who have dense breast tissue (classified as category C or D on breast imaging reports) and who have a routine yearly mammogram at a participating MD Anderson Cancer Center location
- People who are willing to also enrol in a linked study called PA17-0584, or who are already enrolled in it
- People who are willing to take part and are able to give informed consent to participate
Who may not be able to join:
- People who have noticed new breast symptoms since their last mammogram, such as nipple discharge, a lump they can feel, skin dimpling, or pain in one specific area
- People who are currently pregnant, breastfeeding, or have been pregnant or breastfeeding within the last 6 months
- People who have a personal history of breast cancer, including early-stage (non-invasive) or invasive breast cancer
- People who have been treated for any other type of cancer in the past 5 years (exceptions may apply for certain early-stage cervical or skin cancers — confirm with trial site)
- People who have had a breast biopsy within the last 6 months
- People who have had breast surgery within the last 12 months
- People who have had a breast MRI, molecular breast imaging (MBI), or contrast-enhanced mammography (CEM) within the last 24 months
- People with a known allergy to contrast dyes that contain iodine
- People who have had a severe allergic reaction to any substance that required a hospital stay or an IV line to be placed, and who have not previously had a safe exposure to iodine-based IV contrast dye
- People with reduced kidney function, as assessed according to the trial centre's medical guidelines (confirm specific details with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Olena Weaver, MD, M.D. Anderson Cancer Center
Phone: (713) 745-4555
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To identify female MDACC patients with dense breasts who undergo contrast-enhanced mammography
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.